Last reviewed · How we verify

NCT07344675

Fibromyalgia Syndrome and Chronic Pelvic Pain

Completed Last updated 27 February 2026
What this trial tests

trial in Fibromyalgia in 128 participants. Completed in 1 February 2026.

Timeline
1 July 2025
Primary endpoint
15 January 2026
1 February 2026

Quick facts

Lead sponsorSisli Hamidiye Etfal Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment128
Start date1 July 2025
Primary completion15 January 2026
Estimated completion1 February 2026
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Sisli Hamidiye Etfal Training and Research Hospital

Who can join

18 and older, female only, with Fibromyalgia or Fibromyalgia Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to compare patients with and without fibromyalgia syndrome in terms of chronic pelvic pain and pelvic floor dysfunction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Sisli Hamidiye Etfal Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07344675.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing